The latest from the AACC annual meeting and clinical lab expo—before, during, and after the event.
ACD’s easy-to-use RNAscope technology involved in more than 100 peer-reviewed papers in three years; company’s library of target probes exceeds 4,000.
Beckman Coulter has entered into a definitive agreement to purchase the clinical microbiology business of Siemens Healthcare Diagnostics, including the MicroScan line of instruments and consumables.
bioMerieux sepsis facility expansion will help address the global public health threat of sepsis and meet the related demand for microbial detection.
Developer of the world’s first micro lab hires new leadership in preparation for clinical studies and commercialization.
Biochrom Ltd and Gilson have announced a deal to co-market and distribute products for automation of ELISAs and absorbance assays in Europe. Together, Biochrom’s EZ Read microplate readers and Gilson’s liquid handling systems can automate absorbance assays, including ELISA, total protein, and cell viability.
Researchers at Johns Hopkins Bayview Medical Center used simple tactics to reduce the number of blood tests ordered for assessing symptoms of heart attack and chest pain, and to achieve a large decrease in patient charges.
CeGaT, a leading laboratory provider of molecular diagnostic panel tests, has selected N-of-One Inc to provide clinical interpretation of CeGaT’s next-generation sequencing tests performed for cancer patients.
The National Institutes of Health has launched a 4-year, $43 million initiative to engage broad expertise in the study and diagnosis of mystery conditions.
The US Patent and Trademark Office has issued a notice of allowance to Rosetta Genomics for its patent application covering compositions and methods for prognosis and treatment of prostate cancer.